Factors | Virological failure,n (%) | COR(95% CI) | AOR(95% CI) | |
---|---|---|---|---|
Yes | No | |||
Age | ||||
 0–5 years | 34 (21.7) | 123 (78.3) | 2.35 (1.10–5.01) | 2.42 (1.02–5.74)** |
 6–9 years | 15 (10.2) | 132 (89.8) | 0.97 (0.42–2.25) | 1.04 (0.42–2.58) |
 10–15 years | 10 (10.5) | 85 (89.5) | 1 | 1 |
Sex | ||||
 Male | 35 (17.1) | 170 (82.9) | 1.46 (0.83–2.56) | 1.27 (0.68–2.36) |
 Female | 24 (12.4) | 170 (87.6) | 1 | 1 |
Place of residence | ||||
 Outside of Bahir Dar | 14 (19.4) | 58 (80.6) | 1.51 (0.78–2.94) | 1.80 (0.84–3.86) |
 Bahir Dar | 45 (13.8) | 282 (86.2) | 1 | 1 |
Type of health facility | ||||
 Health-center | 27 (18) | 123 (82) | 1.49 (0.85–2.60) | 1.69 (0.89–3.22) |
 Hospital | 32 (12.9) | 217 (87.1) | 1 | 1 |
Child’s HIV status disclosure | ||||
 Not disclosed | 23 (19.5) | 95 (80.5) | 1.65 (0.93–2.93) | 0.85 (0.42–1.72) |
 Disclosed | 36 (12.8) | 245 (87.2) | 1 | 1 |
Baseline WHO clinical Staging | ||||
 Stage III/IV | 21 (30) | 49 (70) | 3.28 (1.78–6.06) | 2.32 (1.14–4.74)** |
 Stage I/II | 38 (11.6) | 291 (88.4) | 1 | 1 |
Opportunistic infection | ||||
 Yes | 33 (26) | 94 (74) | 3.32 (1.89–5.85) | 2.19 (1.13–4.25)** |
 No | 26 (9.6) | 246 (90.4) | 1 | 1 |
WHO clinical Staging (last visit) | ||||
 Stage III/IV | 7 (33.3) | 14 (66.7) | 3.14 (1.21–8.13) | 1.36 (0.44–4.16) |
 Stage I/II | 52 (13.8) | 326 (86.2) | 1 | 1 |
Regimen change/substitute | ||||
 Yes | 51 (15.8) | 271 (84.2) | 1.62 (0.74–3.58) | 1.53 (0.63–3.72) |
 No | 8 (10.4) | 69 (89.6) | 1 | 1 |
Interruption and restart | ||||
 Yes | 18 (27.3) | 48 (72.7) | 2.67 (1.42–5.03) | 2.21 (1.09–4.54)** |
 No | 41 (12.3) | 292 (87.7) | 1 | 1 |
ART adherence | ||||
 Fair/Poor | 20 (29.4) | 48 (70.6) | 3.12 (1.68–5.80) | 2.19 (1.05–4.57)** |
 Good | 39 (11.8) | 292 (88.2) | 1 | 1 |
Duration on ART | ||||
  ≥ 25 months | 53 (15.7) | 285 (84.3) | 1.71 (0.70–4.16) | 2.17 (0.81–5.86) |
  < 25 months | 6 (9.8) | 55 (90.2) | 1 | 1 |